GLSI - Greenwich LifeSciences, Inc. Stock Price, Fair Value and News
14.15USD-0.30 (-2.08%)Delayed
Latest Insider Trading transactions for GLSI
| Datesorted ascending | Name | Buy/Sell | $ Value | # Shares | Avg. Price | Title |
|---|---|---|---|---|---|---|
| 2024-04-01 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-03-22 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-03-20 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-03-05 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-03-04 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-02-16 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2024-02-15 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-11-10 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-11-03 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-10-27 | Premium | bought | Premium | Premium | Premium | VP Clinical Reg Affairs |
| 2023-10-26 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-10-25 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-10-10 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-10-04 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-09-26 | Premium | bought | Premium | Premium | Premium | VP Clinical Reg Affairs |
| 2023-09-19 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-09-11 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-08-22 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-08-04 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-07-21 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-07-13 | Premium | bought | Premium | Premium | Premium | VP Clinical Reg Affairs |
| 2023-05-17 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-04-28 | Premium | bought | Premium | Premium | Premium | VP Clinical Reg Affairs |
| 2023-04-19 | Premium | bought | Premium | Premium | Premium | CEO and CFO |
| 2023-04-18 | Premium | bought | Premium | Premium | Premium | CEO and CFO |